Atlas Trials

A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Dose CC-90001 in Japanese and Caucasian Healthy Subjects

Clinical trial NCT03958864 · COMPLETED

Trial details

NCT number
NCT03958864
Sponsor
Celgene
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteer
Start date
2019-04-04
Primary completion
2019-06-13
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.